drugset / Trial / NCT03195673
Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
Phase 2
Unknown
160 enrolled
Capital Medical University
Beijing Anzhen Hospital · collabThe Luhe Teaching Hospital of the Capital Medical University · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to assess the safety and efficacy of low dosage of Terazosin in Carotid Artery Stenting
Timeline
- Start
- 2018-03-02
- Primary completion
- 2019-11-15
- Completion
- 2019-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terazosin | Small molecule | 0.5 mg | — |